You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 11, November 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Serum β-Carotene, Retinol, and {alpha}-Tocopherol Levels During Mineral Oil Therapy for Constipation

Joseph H. Clark, MD; Gary J. Russell, MD; Joseph F. Fitzgerald, MD; Ken E. Nagamori, MD

Am J Dis Child. 1987;141(11):1210-1212.


Abstract

• Twenty-five children with chronic constipation underwent serial monitoring of serum β-carotene, retinol (vitamin A1), and {alpha}-tocopherol (vitamin E) levels during mineral oil therapy. Mineral oil was administered between meals. Patients were monitored for up to four months of therapy. Mean serum β-carotene levels fell from 1.0±0.5 µmol/L (55.7±26.0 µg/dL) to 0.7±0.4 µmol/L (35.9±22.1 µg/dL) after the first month of mineral oil therapy and remained depressed throughout the remainder of the study. Serum {alpha}-tocopherol levels remained unchanged throughout the observation period. There was a modest increase in serum retinol levels during the study, especially after three months (from 1.48±0.84 µmol/L [42.3±24.1 µg/dL] to 2.22±0.77 µmol/L [63.5±22.1 µg/dL]). We conclude that while a short course of mineral oil can induce a reduction in the serum level of β-carotene, the treatment has no adverse effect on serum levels of retinol and {alpha}-tocopherol.

(AJDC 1987;141:1210-1212)



Author Affiliations

From the Department of Pediatrics, James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis. Dr Clark is now with the Department of Pediatrics, Medical College of Georgia, Augusta.


Footnotes

Accepted for publication June 8, 1987.

Reprint requests to Department of Pediatrics, CK281, Medical College of Georgia, Augusta, GA 30912 (Dr Clark).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Safety of Mineral Oil in the Treatment of Constipation--A Lesson from Prolonged Overdose
Gal-Ezer and Shaoul
CLIN PEDIATR 2006;45:856-858.
ABSTRACT  

Pediatric Constipation Therapy Using Guidelines and Polyethylene Glycol 3350
Bell and Wall
The Annals of Pharmacotherapy 2004;38:686-693.
ABSTRACT | FULL TEXT  

Current topic: Liquid paraffin: a reappraisal of its role in the treatment of constipation
Sharif et al.
Arch. Dis. Child. 2001;85:121-124.
FULL TEXT  

Constipation and Encopresis in Childhood
Abi-Hanna and Lake
Pediatr. Rev. 1998;19:23-31.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.